HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Similar cytogenetic effects of sodium-meglumine diatrizoate and sodium-meglumine ioxithalamate in lymphocytes of patients undergoing brain CT scan.

Abstract
Cytogenetic effects of two ionic contrast media (CM), Urografin 76% a sodium-meglumine diatrizoate, and Telebrix 38, a sodium-meglumine ioxythalamate, were tested on lymphocytes of patients undergoing brain CT Scan. Both compounds have approximately similar iodine concentrations. Chromosomal aberrations were scored in peripheral lymphocytes obtained from 15 patients undergoing brain CT with either urografin 76% or telebrix 38 before and after examination. Results showed no difference in aberration frequency for patients who underwent brain CT without contrast materials compared to controls. However, injection of CM resulted in a high frequency of chromosomal aberrations which significantly differed from controls (P < 0.05). The effect of urografin 76% appeared to be similar to telebrix 38. Therefore, both CM exhibited clastogenic effects on peripheral lymphocytes in vivo. An increase in chromosomal aberrations due to CM used in this study were similar to that reported for other ionic and non-ionic compounds.
AuthorsH Mozdarani, S Fadaei
JournalToxicology letters (Toxicol Lett) Vol. 98 Issue 1-2 Pg. 25-30 (Sep 01 1998) ISSN: 0378-4274 [Print] Netherlands
PMID9776558 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Contrast Media
  • Diatrizoate
  • Iothalamic Acid
  • ioxitalamic acid
Topics
  • Adolescent
  • Adult
  • Brain (diagnostic imaging)
  • Cells, Cultured
  • Chromatids (drug effects, ultrastructure)
  • Chromosome Aberrations
  • Contrast Media (adverse effects)
  • Diatrizoate (adverse effects)
  • Female
  • Humans
  • Iothalamic Acid (adverse effects, analogs & derivatives)
  • Lymphocytes (drug effects, ultrastructure)
  • Male
  • Middle Aged
  • Tomography, X-Ray Computed (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: